Clinical trial
Humoral and Cellular Immune Response Study of Influenza Vaccine
NCT01310374 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Humoral and Cellular Immune Response Study of Influenza Vaccine
- Lead sponsor
- Centers for Disease Control and Prevention, China
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- December 31, 2012
- Enrollment
- 207 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cell mediated reaction, influenza vaccine allergy